The Department of Health (DOH) announces the full implementation of drug price caps starting March 23, 2022 through Executive Order (EO) No. 155 signed by President Rodrigo Duterte. This brings the total number of drugs with maximum drug retail price to 121 molecules or 204 drug formulas, following the first round of price regulation implemented in June 2020 with the signing of EO No. 104 which covered 87 molecules.
The Executive Order (EO) No. 155, “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines,” which was issued by President Rodrigo R. Duterte on 07 December 2021, subjected 34 drug molecules or 71 drug formulas under price regulation through Maximum Wholesale Price (MWP) and Maximum Retail Price (MRP). The implementation shall begin on 23 March 2022.
The Department of Health expressed elation over the signing of Executive Order (EO) No. 155, by President Rodrigo Roa Duterte adding 34 medicines to the list of drugs with mandatory price caps.
DOH informs the public of the adjustments in the Maximum Retail Price (MRP) of certain medicines that are covered by EO 155
Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations Related Posts Maximum Retail Price of Drugs and Medicines 14 Sep 2020 (Executive Order #155) Further Improving Access to Healthcare continue reading : (Department Circular No. 2022-0046) Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations
Effectivity of Executive Order No. 155 “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines” Related Posts Maximum Retail Price of Drugs continue reading : (Department Circular No. 2021-0575) Effectivity of Executive Order No. 155 “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines”
President Duterte inks executive order on new price cap of essential medicines
Access the full document Here
ADVISORY October 25, 2021 RECOMMENDATION TO SUBJECT CERTAIN MEDICINES USED IN THETREATMENT OF COVID-19 UNDER MAXIMUM RETAIL PRICE On 10 September 2021, Proclamation No. 1218 extended the State continue reading : Recommendation to Subject Certain Medicines Used in the Treatment of COVID-19 Under Maximum Retail Price
Compliance to the Labelling Requirements for Medicines under the Maximum Retail Price Related Posts Mark-up Regulation of Essential Medicines in DOH Facilities 07 Oct 2020 Drug Price Reference Index 07 continue reading : Compliance to the Labelling Requirements for Medicines under the Maximum Retail Price
MRP Poster (English) MRP Poster (Filipino) Related Posts DOH Program on Combating Antimicrobial Resistance 14 Oct 2020 Philippine Standard time Contact Us: Telephone Number: 02-8757734 Loc. 253 Address: 4th Floor, continue reading : New Standard Information, Education and Communication Material for the Implementation of the Maximum Retail Price (MRP) for Drugs and Medicines, NOW AVAILABLE!